» Articles » PMID: 21145874

New Assessment of Hepatic Encephalopathy

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2010 Dec 15
PMID 21145874
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic encephalopathy (HE) is a common complication of cirrhosis that requires careful appraisal of the clinical manifestations, evaluation of the underlying neurological disorders, and assessment of liver function and the portal-systemic circulation. This article reviews recent developments in the assessment of HE and discusses the controversy regarding the use of a categorical or a continuous approach in measuring the severity of this condition. New scales facilitate effective monitoring and assessment of episodic HE. Neuropsychological test batteries and neurophysiological tests are of value for evaluating cognitive function in outpatients and can establish the diagnosis of minimal HE, and the severity of low-grade HE. These tools allow better evaluation of the origin of cognitive complaints and help in estimating the risk of accidents. It is now possible to complete the evaluation with measurement of the effects of cognitive impairment on daily living. In difficult cases, imaging of the brain and portal-systemic circulation with magnetic resonance imaging is especially helpful. Based on these studies, neurological signs and symptoms can be attributed to HE in patients with mild liver disease and in those with complex neurological manifestations. The new methods presented are also valuable for investigating the neurological manifestations occurring after liver transplantation.

Citing Articles

Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis.

Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I Nutrients. 2025; 17(2.

PMID: 39861356 PMC: 11768058. DOI: 10.3390/nu17020226.


Neutrophil PAD4 Expression and Its Pivotal Role in Assessment of Alcohol-Related Liver Disease.

Rycyk-Bojarzynska A, Kasztelan-Szczerbinska B, Cichoz-Lach H, Surdacka A, Rolinski J Int J Mol Sci. 2024; 25(14).

PMID: 39062840 PMC: 11276781. DOI: 10.3390/ijms25147597.


Investigation of Post-Transplant Mental Well-Being in Liver Transplant Recipients with Hepatic Encephalopathy.

Saritas S, Tarlaci S, Bulbuloglu S, Gunes H J Clin Med. 2024; 13(11).

PMID: 38892960 PMC: 11172876. DOI: 10.3390/jcm13113249.


Feasibility exploration of GSH in the treatment of acute hepatic encephalopathy from the aspects of pharmacokinetics, pharmacodynamics, and mechanism.

Hu K, Xu Y, Fan J, Liu H, Di C, Xu F Front Pharmacol. 2024; 15:1387409.

PMID: 38887546 PMC: 11181355. DOI: 10.3389/fphar.2024.1387409.


Human Neutrophil Alpha-Defensins Promote NETosis and Liver Injury in Alcohol-Related Liver Cirrhosis: Potential Therapeutic Agents.

Rycyk-Bojarzynska A, Kasztelan-Szczerbinska B, Cichoz-Lach H, Surdacka A, Rolinski J J Clin Med. 2024; 13(5).

PMID: 38592082 PMC: 10931661. DOI: 10.3390/jcm13051237.